Monitoring intracellular labile iron pools: A novel fluorescent iron(III) sensor as a potential non-invasive diagnosis tool

Journal of Pharmaceutical Sciences

Volumn 98, Issue 6, 2009, Pages 2212-2226

  Fakih, Sarah ^a   Podinovskaia, Maria ^b   Kong, Xiaole ^c   Schaible, Ulrich E ^b   Collins, Helen L ^c   Hider, Robert C ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

3 hydroxypyridin 4 ones (HPO); Chelation; Flow cytometry; Fluorescence spectroscopy; Imaging methods; Iron sensors; Labile iron; logP; Therapeutic drug monitoring

Indexed keywords

3 HYDROXY 4 PYRIDONE DERIVATIVE; FLUORESCEIN; IRON; IRON CHELATING AGENT;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL COMPARTMENTALIZATION; CELL MIGRATION; CELL ORGANELLE; CHELATION; CONFOCAL MICROSCOPY; DIAGNOSTIC PROCEDURE; ENDOSOME; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; HOMEOSTASIS; IRON OVERLOAD; MACROPHAGE; MONITORING; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; PHYSICAL CHEMISTRY; SENSITIVITY ANALYSIS; SENSOR;

EID: 67049097553     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21583     Document Type: Article

References (54)

1. Kaim W, Schwederski B. 1995. Bioinorganic chemistry. 2nd edition Stuttgart: B.G. Teubner.
2. Jacobs A. 1977. Low molecular weight intracellular iron transport compounds. Blood 50:433-439. (Pubitemid 8180426)
3. Halliwell B, Gutteridge JMC. 1990. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 186:1-85. (Pubitemid 20279941)
4. Petrat F, De Groot H, Sustmann R, Rauen U. 2002. The chelatable iron pool in living cells: A methodically defined quantity. Biol Chem 383:489-502. (Pubitemid 34506286)
5. Kakhlon O, Cabantchik ZI. 2002. The labile iron pool: Characterization, measurement, and participation in cellular processes. Free Radical Biol Med 33:1037-1046.
6. Halliwell B, Gutteridge JMC. 1992. Biologically relevant metal ion-dependent hydroxyl radical generation. An update. FEBS Lett 307:108-112.
7. Bacon BR, Britton RS. 1989. Hepatic injury in chronic iron overload. Role of lipid peroxidation. Chem Biol Interact 70:183-226.
8. Bacon BR, Britton RS. 1990. The pathology of hepatic iron overload: A free radical-mediated process? Hepatology 11:127-137.
9. Kehrer JP. 2000. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 149:43-50. (Pubitemid 30645786)
10. Kowdley KV. 2004. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 127:S79-S86. (Pubitemid 39423373)
11. Gaeta A, Hider RC. 2005. The crucial role of metal ions in neurodegeneration: The basis for a promising therapeutic strategy. Br J Pharmacol 146:1041-1059. (Pubitemid 41786957)
12. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 1:1-40. (Pubitemid 43227479)
13. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84. (Pubitemid 44566469)
14. Molina-Holgado M, Hider RC, Gaeta A, Williams R, Francis P. 2007. Metal ions and neurodegeneration. Biometals 20:639-654.
15. Breuer W, Epsztejn S, Millgram P, Cabantchik ZI. 1995. Transport of iron and other transition metals into cells as revealed by a fluorescent probe. Am J Physiol Cell Phys 268:C1354-C1361.
16. Breuer W, Epsztejn S, Cabantchik ZI. 1995. Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J Biol Chem 270:24209-24215.
17. Epsztejn S, Kakhlon O, Glickstein H, Breuer W, Cabantchik ZI. 1997. Fluorescence analysis of the labile iron pool of mammalian cells. Anal Biochem 248:31-40. (Pubitemid 27218221)
18. Petrat F, De Groot H, Rauen U. 2000. Determination of the chelatable iron pool of single intact cells by laser scanning microscopy. Arch Biochem Biophys 376:74-81. (Pubitemid 30205116)
19. Petrat F, Rauen U, De Groot H. 1999. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe phen green SK. Hepatology 29:1171-1179. (Pubitemid 29168752)
20. Petrat F, De Groot H, Rauen U. 2001. Subcellular distribution of chelatable iron: A laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem J 356:61-69. (Pubitemid 34275706)
21. Petrat F, Weisheit D, Lensen M, De Groot H, Sustmann R, Rauen U. 2002. Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. Biochem J 362:137-147. (Pubitemid 34174471)
22. Rauen U, Springer A, Weisheit D, Petrat F, Korth HG, de Groot H, Sustmann R. 2007. Assessment of chelatable mitochondrial iron by using mitochondrion-selective fluorescent iron indicators with different iron-binding affinities. Chembiochem 8:341-352. (Pubitemid 47194515)
23. Glickstein H, El RB, Link G, Breuer W, Konijn AM, Hershko C, Nick H, Cabantchik ZI. 2006. Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences. Blood 108:3195-3203. (Pubitemid 44776962)
24. Yu Z, Persson HL, Eaton JW, Brunk UT. 2003. Intralysosomal iron: A major determinant of oxidant-induced cell death. Free Radical Biol Med 34:1243-1252. (Pubitemid 36513967)
25. Terman A, Gustafsson B, Brunk UT. 2006. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem Biol Interact 163:29-37. (Pubitemid 44572212)
26. Kurz T, Terman A, Gustafsson B, Brunk UT. 2008. Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol 129:389-406.
27. Kurz T, Leake A, von Zglinicki T, Brunk UT. 2004. Lysosomal redox-active iron is important for oxidative stress-induced DNA damage. Ann NY Acad Sci 1019:285-288. (Pubitemid 38951321)
28. Kurz T, Leake A, von Zglinicki T, Brunk UT. 2004. Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage. Biochem J 378:1039-1045. (Pubitemid 38406883)
29. Kurz T, Terman A, Gustafsson B, Brunk UT. 2008. Lysosomes and oxidative stress in aging and apoptosis. Biochim Biophys Acta 1781:1291-1303.
30. Loyevsky M, John C, Dickens B, Hu V, Miller JH, Gordeuk V. 1999. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators. Mol Biochem Parasitol 101:43-59. (Pubitemid 29257840)
31. Darbari D, Loyevsky M, Gordeuk V, Kark JA, Castro O, Rana S, Apprey V, Kurantsin-Mills J. 2003. Fluorescence measurements of the labile iron pool of sickle erythrocytes. Blood 102:357-364. (Pubitemid 36759677)
32. Glickstein H, El RB, Shvartsman M, Cabantchik ZI. 2005. Intracellular labile iron pools as direct targets of iron chelators: A fluorescence study of chelator action in living cells. Blood 106:3242-3250. (Pubitemid 41565925)
33. Ma Y, Luo W, Quinn PJ, Liu ZD, Hider RC. 2004. Design, synthesis, physicochemical properties, and evaluation of novel iron chelators with fluorescent sensors. J Med Chem 47:6349-6362. (Pubitemid 39587258)
34. Luo W, Ma Y, Quinn PJ, Hider RC, Liu Z. 2004. Design, synthesis and properties of novel iron(III)-specific fluorescent probes. J Pharm Pharmacol 56:529-536. (Pubitemid 38455619)
35. Ma Y, De Groot H, Liu Z, Hider RC, Petrat F. 2006. Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes. Biochem J 395:49-55.
36. Fakih S, Podinovskaia M, Kong XL, Collins HL, Schaible UE, Hider RC. 2008. Targeting the lysosome: Fluorescent iron(III) chelators to selectively monitor endosomal/lysosomal labile iron pools. J Med Chem 51:4539-4552.
37. Zhou T, Neubert H, Liu DY, Ma Y, Kong XL, Luo W, Sykes M, Hider RC. 2006. Iron binding dendrimers: A novel approach for the treatment of haemochromatosis. J Med Chem 49:4171-4182. (Pubitemid 44043105)
38. Tanaka K, Miura T, Umezawa N, Urano Y, Kikuchi K, Higuchi T, Nagano T. 2001. Rational design of fluorescein-based probes. mechanism-based design of a maximum fluorescence probe for singlet oxygen. J Am Chem Soc 123:2530-2536. (Pubitemid 32888554)
39. Ueno T, Urano Y, Setsukinai K, Takakusa H, Kojima H, Kikuchi K, Ohkubo K, Fukuzumi S, Nagano T. 2004. Rational principles for modulating fluorescence properties of fluorescein. J Am Chem Soc 126:14079-14085. (Pubitemid 39447086)
40. 3+ values. J Med Chem 42:4814-4823.
41. Wis Vitolo LM, Hefter GT, Clare BW, Webb J. 1990. Iron chelators of the pyridoxal isonicotinoyl hydrazone Part II. Formation constants with iron(III) and iron(II). Inorg Chim Acta 170:171-176.
42. Harris DC, Aisen P. 1973. Facilitation of Fe(II) autoxidation by Fe(III) complexing agents. Biochem Biophys Acta 329:156-158.
43. Dobbin PS, Hider RC, Hall AD, Taylor PD, Sarpong P, Porter JB, Xiao G, van der Helm D. 1993. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-Alkyl-3-hydroxy-4(1H)-pyridinones: Orally active iron chelators with clinical potential. J Med Chem 36:2448-2458. (Pubitemid 23270794)
44. Rai BL, Dekhordi LS, Khodr H, Jin Y, Liu Z, Hider RC. 1998. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy- 4(1H)-pyridinones. J Med Chem 41:3347-3359. (Pubitemid 28406542)
45. Lloyd JB, VCable H, Rice-Evans C. 1991. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochem Pharmacol 41:1361-1363.
46. Schaible UE, Kaufmann SHE. 2002. Studying trafficking of intracellular pathogens in antigen-presenting cells. Methods Microbiol 31:343-360.
47. Muir AR, Goldberg L. 1961. Observations on subcutaneous macrophages. Phagocytosis of iron dextran and ferritin synthesis. Q J Exp Physiol Cogn Med Sci 46:289-298.
48. Ternes N, Scheiber-Mojdehkar B, Landgraf G, Goldenberg H, Sturm B. 2007. Iron availability and complex stability of iron hydroxyethyl starch and iron dextran - a comparative in vitro study with liver cells and macrophages. Nephrol Dial Transplant 22:2824-2830. (Pubitemid 350093433)
49. Theurl I, Ludwiczek S, Eller P, Seifert M, Artner E, Brunner P, Weiss G. 2005. Pathways for the regulation of body iron homeostasis in response to experimental iron overload. J Hepatol 43:711-719. (Pubitemid 41253240)
50. Bright NA, Gratian MJ, Luzio JP. 2005. Endocytic delivery to lysosomes mediated by concurrent fusion and kissing events in living cells. Curr Biol 15:360-365. (Pubitemid 40263370)
51. Luzio JP, Poupon V, Lindsay MR, Mullock BM, Piper RC, Pryor PR. 2003. Membrane dynamics and the biogenesis of lysosomes (Review). Mol Membr Biol 20:141-154. (Pubitemid 36841704)
52. Harris WR, Raymond KN, Weitl FL. 1981. Ferric ion sequestering agents. 6. The spectrophotometric and potentiometric evaluation of sulfonated trichatecholate ligands. J Am Chem Soc 103:2667-2675.
53. Andrews NC. 1999. Disorders of iron metabolism. N Engl J Med 341:1986-1995. (Pubitemid 30010408)
54. Ma Y, Luo W, Camplo M, Liu Z, Hider RC. 2005. Novel iron-specific fluorescent probes. Bioorg Med Chem Lett 15:3450. (Pubitemid 40835754)